華人策略控股(08089.HK)擬收購一家旅遊公司100%股權
格隆匯2月5日丨華人策略控股(08089.HK)公佈,於2020年2月5日,公司間接全資附屬公司Magic Red Limited(買方)與賣方訂立諒解備忘錄,內容有關可能收購目標公司全部已發行股本。
目標公司主要於香港及大中華地區從事入境遊業務及旅遊相關服務超過30年曆史。截至2018年3月31日止年度,目標公司取得收入約港幣2.9億元及除税前溢利約港幣1243萬元,因此,董事會相信目標公司能提升該集團的競爭力及盈利能力。
董事認為,可能收購一旦落實,將為集團提供良機,以擴張其業務及為股東帶來最大回報,併為集團提供資本增值潛力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.